Cerus
CERS
#7486
Rank
C$0.57 B
Marketcap
C$3.00
Share price
-4.15%
Change (1 day)
12.61%
Change (1 year)

Earnings for Cerus (CERS)

Earnings in 2025 (TTM): -C$10.25 Million

According to Cerus's latest financial reports the company's current earnings are C$0.19 Billion. In 2024 the company made an earning of -C$16.25 Million, an increase over its 2023 earnings that were of -C$39.58 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cerus from 1997 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -C$10.25 Million-36.97%
2024 -C$16.25 Million-58.95%
2023 -C$39.58 Million-20.74%
2022 -C$49.94 Million-25.7%
2021 -C$67.21 Million-11.99%
2020 -C$76.36 Million-14%
2019 -C$88.8 Million21.73%
2018 -C$72.94 Million-0.65%
2017 -C$73.42 Million-10.96%
2016 -C$82.46 Million4.24%
2015 -C$79.11 Million50.99%
2014 -C$52.4 Million-10.08%
2013 -C$58.27 Million184.13%
2012 -C$20.51 Million-7.91%
2011 -C$22.27 Million
2009 -C$31.45 Million-24.69%
2008 -C$41.76 Million-25.2%
2007 -C$55.83 Million330.54%
2006 -C$12.97 Million1.49%
2005 -C$12.78 Million-61.02%
2004 -C$32.78 Million
2002 -C$81.08 Million10.02%
2001 -C$73.7 Million34.25%
2000 -C$54.9 Million61.02%
1999 -C$34.1 Million-18.81%
1998 -C$42 Million93.08%
1997 -C$21.75 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Boston Scientific
BSX
C$4.47 B-45,284.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Utah Medical Products
UTMD
C$19.99 M-301.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Haemonetics
HAE
C$0.33 B-3,453.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-C$12.98 Million 31.12%๐Ÿ‡บ๐Ÿ‡ธ USA